Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study
The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · e3719-e3729
DOI: 10.1210/clinem/dgaf154 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 06.03.2025. Verfasst von Marta Araujo-Castro und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid 28034, Spain. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Hypertension, Adrenalectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Context
Postoperative outcomes of patients with normotensive pheochromocytomas are poorly documented.
Objective
We aimed to evaluate the impact of preoperative hypertension on postoperative outcomes following adrenalectomy for pheochromocytoma.
Methods
An international retrospective study of patients undergoing adrenalectomy for pheochromocytoma in 46 centers between 2012 and 2022 was performed. Hypertensive and normotensive pheochromocytoma were defined respectively by the presence or absence of hypertension history before or at the time of pheochromocytoma diagnosis. To evaluate differences in postoperative outcomes between hypertensive and normotensive patients, propensity score matched (PSM) analysis was performed.
Results
Among 2016 patients with pheochromocytoma, 1034 (51.2%) had preoperative hypertension and 982 (49.8%) were normotensive. Hypertensive patients were 4.5 years older (P < .001), had a higher prevalence of type 2 diabetes (P < .001), had a higher median Charlson Comorbidity Index (2.0 vs 1.0; P < .001), and had an American Society of Anesthesiologists score of III to IV more frequently (41% vs 19.9%; P < .001) than normotensive patients. Nonadjusted analysis demonstrated that hypertensive patients had longer operative time (115.0 vs 103.5 minutes; P = .026), higher rate of vasopressors at skin closure (19.7% vs 15.4%; P = .013), more perioperative blood transfusions (7.7% vs 5.0%; P = .016), and an increased complication rate (21.6% vs 17.7%; P = .029). However, after 1:1 PSM, we found that readmission, complications, and serious complications were similar between cohorts.
Conclusion
Patients with hypertensive pheochromocytomas have a higher risk of postoperative complications than normotensive patients due to the association of hypertension with a higher burden of comorbidities and older age. However, hypertension is not an independent risk factor of postoperative complications after pheochromocytoma surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid 28034, Spain.
- Instituto de Investigación Ramón y Cajal (YRICIS), Madrid 28034, Spain.
- Department of Endocrinology and Nutrition, University Hospital Reina Sofia, Cordoba 14004, Spain.
- Department of Urology, The First Affiliated Hospital of Jilin University, Changchun, Jilin 2699, China.
- Division of General, Endocrine and Transplant Surgery, Medical University of Gdańsk, Gdańsk 80210, Poland.
- UOC Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Centro di Ricerca in Chirurgia Endocrina e dell'Obesità, Università Cattolica del Sacro Cuore, Rome 00136, Italy.
ORCID-Profile: Marta Araujo-Castro, Marco Raffaelli, Francesco Pennestrì, Alexander J Papachristos, Maurizio Iacobone, Ozer Makay, Anton F Engelsman, Isabelle Holscher, Helen Perry, Cristina Lamas
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Araujo-Castro, M., Herrera, A., Wang, Y., Wang, Z., Śledziński, M., Hellmann, A., Raffaelli, M., Pennestrì, F., Sywak, M., Papachristos, A. J., Palazzo, F. F., Sung, T. Y., Kim, B. C., Lee, Y. M., Eatock, F., Anderson, H., Iacobone, M., Daukša, A., Makay, O., …, & García Sanz, I. (2025). Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study. The Journal of Clinical Endocrinology & Metabolism, 110(11), e3719-e3729. https://doi.org/10.1210/clinem/dgaf154
Vancouver
Araujo-Castro M, Herrera A, Wang Y, Wang Z, Śledziński M, Hellmann A, et al. Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):e3719-e3729. doi:10.1210/clinem/dgaf154
BibTeX
@article{AraujoCastro2025,
author = {Araujo-Castro, Marta and Herrera, Aura and Wang, Yanbo and Wang, Zhicheng and Śledziński, Maciej and Hellmann, Andrzej and Raffaelli, Marco and Pennestrì, Francesco and Sywak, Mark and Papachristos, Alexander J and Palazzo, Fausto F and Sung, Tae-Yon and Kim, Byung-Chang and Lee, Yu-Mi and Eatock, Fiona and Anderson, Hannah and Iacobone, Maurizio and Daukša, Albertas and Makay, Ozer and Turk, Yigit and Basut Atalay, Hafize and Nieveen van Dijkum, Els J M and Engelsman, Anton F and Holscher, Isabelle and Materazzi, Gabriele and Rossi, Leonardo and Becucci, Chiara and Shore, Susannah L and Fung, Clare and Waghorn, Alison and Mihai, Radu and Balasubramanian, Sabapathy P and Pannu, Arslan and Tatarano, Shuichi and Velázquez-Fernández, David and Miller, Julie A and Serrao-Brown, Hazel and Chen, Yufei and Demarchi, Marco Stefano and Djafarrian, Reza and Doran, Helen and Wang, Kelvin and Stechman, Michael J and Perry, Helen and Hubbard, Johnathan and Lamas, Cristina and Mercer, Philippa and MacPherson, Janet and Lumbiganon, Supanut and Calatayud, María and Hanzu, Felicia Alexandra and Vidal, Oscar and Minguez Ojeda, Cesar and Papavramidis, Theodosios and Rodríguez de Vera Gómez, Pablo and Aldrees, Abdulaziz and Altwjry, Tariq and Valdés, Nuria and Álvarez-Escola, Cristina and García Sanz, Iñigo},
title = {Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {11},
pages = {e3719--e3729},
doi = {10.1210/clinem/dgaf154}
}
EUVIMED